Literature DB >> 12163589

Consistent patterns in the development and immunodominance of human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T-cell responses following acute HIV-1 infection.

Xu G Yu1, Marylyn M Addo, Eric S Rosenberg, William R Rodriguez, Paul K Lee, Cecily A Fitzpatrick, Mary N Johnston, Daryld Strick, Philip J R Goulder, Bruce D Walker, Marcus Altfeld.   

Abstract

Human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T-cell responses generated during acute infection play a critical role in the initial control of viremia. However, little is known about the viral T-cell epitopes targeted during acute infection or about their hierarchy in appearance and relative immunodominance over time. In this study, HIV-1-specific CD8+ T-cell responses in 18 acutely infected individuals expressing HLA-A3 and/or -B7 were characterized. Detailed analysis of CD8 responses in one such person who underwent treatment of acute infection followed by reexposure to HIV-1 through supervised treatment interruptions (STI) revealed recognition of only two cytotoxic T-lymphocyte (CTL) epitopes during symptomatic acute infection. HIV-1-specific CD8+ T-cell responses broadened significantly during subsequent exposure to the virus, ultimately targeting 27 distinct CTL epitopes, including 15 different CTL epitopes restricted by a single HLA class I allele (HLA-A3). The same few peptides were consistently targeted in an additional 17 persons expressing HLA-A3 and/or -B7 during acute infection. These studies demonstrate a consistent pattern in the development of epitope-specific responses restricted by a single HLA allele during acute HIV-1 infection, as well as persistence of the initial pattern of immunodominance during subsequent STI. In addition, they demonstrate that HIV-1-specific CD8+ T-cell responses can ultimately target a previously unexpected and unprecedented number of epitopes in a single infected individual, even though these are not detectable during the initial exposure to virus. These studies have important implications for vaccine design and evaluation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12163589      PMCID: PMC136975          DOI: 10.1128/jvi.76.17.8690-8701.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

Review 1.  The role of CD4(+) T helper cells in the cytotoxic T lymphocyte response to HIV-1.

Authors:  M Altfeld; E S Rosenberg
Journal:  Curr Opin Immunol       Date:  2000-08       Impact factor: 7.486

Review 2.  Anti-HIV cellular immunity: recent advances towards vaccine design.

Authors:  P J Goulder; S L Rowland-Jones; A J McMichael; B D Walker
Journal:  AIDS       Date:  1999       Impact factor: 4.177

3.  HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression.

Authors:  C J Pitcher; C Quittner; D M Peterson; M Connors; R A Koup; V C Maino; L J Picker
Journal:  Nat Med       Date:  1999-05       Impact factor: 53.440

4.  HLA supertypes and supermotifs: a functional perspective on HLA polymorphism.

Authors:  A Sette; J Sidney
Journal:  Curr Opin Immunol       Date:  1998-08       Impact factor: 7.486

5.  Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes.

Authors:  J E Schmitz; M J Kuroda; S Santra; V G Sasseville; M A Simon; M A Lifton; P Racz; K Tenner-Racz; M Dalesandro; B J Scallon; J Ghrayeb; M A Forman; D C Montefiori; E P Rieber; N L Letvin; K A Reimann
Journal:  Science       Date:  1999-02-05       Impact factor: 47.728

6.  Liver-derived CTL in hepatitis C virus infection: breadth and specificity of responses in a cohort of persons with chronic infection.

Authors:  D K Wong; D D Dudley; N H Afdhal; J Dienstag; C M Rice; L Wang; M Houghton; B D Walker; M J Koziel
Journal:  J Immunol       Date:  1998-02-01       Impact factor: 5.422

7.  HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy.

Authors:  G M Ortiz; D F Nixon; A Trkola; J Binley; X Jin; S Bonhoeffer; P J Kuebler; S M Donahoe; M A Demoitie; W M Kakimoto; T Ketas; B Clas; J J Heymann; L Zhang; Y Cao; A Hurley; J P Moore; D D Ho; M Markowitz
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

Review 8.  Memory CD8+ T cells in HIV infection.

Authors:  A J McMichael; G Ogg; J Wilson; M Callan; S Hambleton; V Appay; T Kelleher; S Rowland-Jones
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2000-03-29       Impact factor: 6.237

9.  Autologous strain-specific cytolytic T lymphocyte responses directed against human immunodeficiency virus type 1 Env.

Authors:  S C Ray; N Lubaki; B R Dhruva; R F Siliciano; R C Bollinger
Journal:  AIDS Res Hum Retroviruses       Date:  1998-01-01       Impact factor: 2.205

10.  Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques.

Authors:  X Jin; D E Bauer; S E Tuttleton; S Lewin; A Gettie; J Blanchard; C E Irwin; J T Safrit; J Mittler; L Weinberger; L G Kostrikis; L Zhang; A S Perelson; D D Ho
Journal:  J Exp Med       Date:  1999-03-15       Impact factor: 14.307

View more
  56 in total

1.  Influence of dominant HIV-1 epitopes on HLA-A3/peptide complex formation.

Authors:  Judith Racape; Francine Connan; Johan Hoebeke; Jeannine Choppin; Jean-Gérard Guillet
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-20       Impact factor: 11.205

2.  Analysis of pigtail macaque major histocompatibility complex class I molecules presenting immunodominant simian immunodeficiency virus epitopes.

Authors:  Miranda Z Smith; C Jane Dale; Robert De Rose; Ivan Stratov; Caroline S Fernandez; Andrew G Brooks; Jason Weinfurter; Kendall Krebs; Cara Riek; David I Watkins; David H O'connor; Stephen J Kent
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

3.  Potentially exposed but uninfected individuals produce cytotoxic and polyfunctional human immunodeficiency virus type 1-specific CD8(+) T-cell responses which can be defined to the epitope level.

Authors:  A L Erickson; C B Willberg; V McMahan; A Liu; S P Buchbinder; L A Grohskopf; R M Grant; D F Nixon
Journal:  Clin Vaccine Immunol       Date:  2008-09-24

4.  Safety and Immunogenicity of a Randomized Phase 1 Prime-Boost Trial With ALVAC-HIV (vCP205) and Oligomeric Glycoprotein 160 From HIV-1 Strains MN and LAI-2 Adjuvanted in Alum or Polyphosphazene.

Authors:  Robert J O'Connell; Jean-Louis Excler; Victoria R Polonis; Silvia Ratto-Kim; Josephine Cox; Linda L Jagodzinski; Michelle Liu; Lindsay Wieczorek; John G McNeil; Raphaelle El-Habib; Nelson L Michael; Bruce L Gilliam; Robert Paris; Thomas C VanCott; Georgia D Tomaras; Deborah L Birx; Merlin L Robb; Jerome H Kim
Journal:  J Infect Dis       Date:  2016-02-11       Impact factor: 5.226

5.  Variable HIV peptide stability in human cytosol is critical to epitope presentation and immune escape.

Authors:  Estibaliz Lazaro; Carl Kadie; Pamela Stamegna; Shao Chong Zhang; Pauline Gourdain; Nicole Y Lai; Mei Zhang; Sergio A Martinez; David Heckerman; Sylvie Le Gall
Journal:  J Clin Invest       Date:  2011-05-09       Impact factor: 14.808

6.  Vertical T cell immunodominance and epitope entropy determine HIV-1 escape.

Authors:  Michael K P Liu; Natalie Hawkins; Adam J Ritchie; Vitaly V Ganusov; Victoria Whale; Simon Brackenridge; Hui Li; Jeffrey W Pavlicek; Fangping Cai; Melissa Rose-Abrahams; Florette Treurnicht; Peter Hraber; Catherine Riou; Clive Gray; Guido Ferrari; Rachel Tanner; Li-Hua Ping; Jeffrey A Anderson; Ronald Swanstrom; Myron Cohen; Salim S Abdool Karim; Barton Haynes; Persephone Borrow; Alan S Perelson; George M Shaw; Beatrice H Hahn; Carolyn Williamson; Bette T Korber; Feng Gao; Steve Self; Andrew McMichael; Nilu Goonetilleke
Journal:  J Clin Invest       Date:  2012-12-10       Impact factor: 14.808

7.  Conserved HIV-1 epitopes continuously elicit subdominant cytotoxic T-lymphocyte responses.

Authors:  Yi Liu; John McNevin; Morgane Rolland; Hong Zhao; Wenjie Deng; Janine Maenza; Claire E Stevens; Ann C Collier; M Juliana McElrath; James I Mullins
Journal:  J Infect Dis       Date:  2009-12-15       Impact factor: 5.226

8.  Comprehensive analysis of human immunodeficiency virus type 1-specific CD4 responses reveals marked immunodominance of gag and nef and the presence of broadly recognized peptides.

Authors:  Daniel E Kaufmann; Paul M Bailey; John Sidney; Bradford Wagner; Philip J Norris; Mary N Johnston; Lisa A Cosimi; Marylyn M Addo; Mathias Lichterfeld; Marcus Altfeld; Nicole Frahm; Christian Brander; Alessandro Sette; Bruce D Walker; Eric S Rosenberg
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

9.  Maintenance or emergence of chronic phase secondary cytotoxic T lymphocyte responses after loss of acute phase immunodominant responses does not protect SIV-infected rhesus macaques from disease progression.

Authors:  M Shannon Keckler; Vida L Hodara; Laura M Parodi; Luis D Giavedoni
Journal:  J Biomed Biotechnol       Date:  2010-05-25

10.  Optimizing peptide matrices for identifying T-cell antigens.

Authors:  Melissa L Precopio; Tiffany R Butterfield; Joseph P Casazza; Susan J Little; Douglas D Richman; Richard A Koup; Mario Roederer
Journal:  Cytometry A       Date:  2008-11       Impact factor: 4.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.